Celsion CORP

LAWRENCEVILLE, NJ How do I update this listing?

Create Email Alert

Celsion Corp is based out of Lawrenceville. Celsion is an oncology drug development company focused on the development of treatments for those suffering with cancer. Co. is working to develop and commercialize targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. Co.'s main product ThermoDox�� is being evaluated in a Phase III clinical trial for primary liver cancer, a Phase II clinical trial for colorectal liver metastasis and a Phase II clinical trial for recurrent chest wall breast cancer. ThermoDox�� is a liposomal encapsulation of doxorubicin, an oncology drug for the treatment of a range of cancers.Whalewisdom has at least 134 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-06-08. The notice included securities offered of Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

celsion corp
997 LENOX DRIVE
LAWRENCEVILLE NJ    08648

Business Phone: (609) 896-9100
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-06-08 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,070,000 5,070,000 0
2014-06-24 D PHARMACEUTICALS Equity 8,500,000 8,500,000 0
2011-06-14 D PHARMACEUTICALS Equity 8,580,000 8,580,000 0
2010-07-26 D PHARMACEUTICALS Equity 15,139,744 139,744 15,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALBERTO R MARTINEZ subscription required
    DIRECTOR
AUGUSTINE CHOW subscription required
    DIRECTOR
FREDERICK J. FRITZ subscription required
    DIRECTOR
GARY W. PACE subscription required
    DIRECTOR
GREGORY WEAVER subscription required
    DIRECTOR
JEFFREY W. CHURCH subscription required
    EXECUTIVE OFFICER
KHURSHEED ANWER subscription required
    EXECUTIVE OFFICER
MAX E. LINK subscription required
    DIRECTOR
MICHAEL H. TARDUGNO subscription required
    EXECUTIVE OFFICER DIRECTOR
NICHOLAS BORYS subscription required
    EXECUTIVE OFFICER
ROBERT W HOOPER subscription required
    DIRECTOR
ROBERT A REED subscription required
    EXECUTIVE OFFICER
TIMOTHY J. TUMMINELLO subscription required
    EXECUTIVE OFFICER

Elevate your investments